Reliable data on sales and use of antimicrobial medicinal products in animals help identify trends and possible risk factors for human and animal health.
EU / EEA Member States can use those insights to better design measures on the prudent use of antimicrobials, which can contribute to fight antimicrobial resistance. It can also help to evaluate the impact of those measures on public health.
EMA developed the platform under the Veterinary Medicinal Products Regulation (Article 57 of Regulation (EU) 2019/6).
From 2010 to 2023, Member States cooperated on a voluntary basis under the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project.
For more information, see:
How to use the platform
All EU / EEA Member States must use the Antimicrobial Sales and Use Platform to report to EMA their data on thevolume of sales and use of antimicrobial medicinal products in animals.
Use the link below to access the platform via the Union Product Database:
The platform only permits the upload of data in standardised formats.This enables data validation and automated calculation of antimicrobial amount.
All Member States must report their data in line with the relevant EU legislation:
Timeline for implementation
From January 2024, all EU / EEA Member States must report their data on the volume of sales and use of antimicrobial medicinal products in animals to EMA on an annual basis.
EMA will publish the first annual report in March 2025.
From 2025 onwards, EMA will publish its annual report before 31 December each year.
The reporting of data on use in animal species will be implemented gradually. The table below details the year in which Member States must start reporting data for different animal species:
|First reporting year
|Cattle, pigs, chicken, turkeys
|Other poultry (duck and geese), sheep, goats, finfish (Atlantic salmon, Rainbow trout, Gilthead seabream, European seabass, Common carp), horses, rabbits, any other food-producing animals of relevance to the Member State
|Non-food-producing-animal species: dogs, cats, fur animals (minks and foxes)
Guidance for EU / EEA Member States
Guidance is available to help national competent authorities implement the legislative requirements for reporting sales and use of antimicrobial medicinal products in animals.
These documents, developed by EMA with experts from the EU / EEA network, contain the technical specifications that Member States need to on the sales and use of antimicrobial medicinal products in animals. The specifications are in line with the legislation.
EMA will make updated versions of these documents available in a timely manner.
Guideline on the reporting of antimicrobial sales and use in animals at the EU level – denominators and indicators
Overview of comments - Guideline on the reporting of antimicrobial sales and use in animals at the EU level – denominators and indicators
Antimicrobial use data reporting per animal categories (numerator) - Manual for reporting the data to EMA
Draft concept paper on the reporting of antimicrobial sales and use in animals at the EU level
Reporting protocols and templates
EMA makes available the necessary protocols and templates for EU / EEA national competent authorities to report data on antimicrobials sales, use and animal populations:
Antimicrobial Sales and Use (ASU) technical implementation protocol
Antimicrobial Sales and Use (ASU) Power BI Application
Antimicrobial Sales and Use (ASU) Platform User Guide
Antimicrobial Sales and Use (ASU) - Sales data template
Antimicrobial Sales and Use (ASU) - Use data template
Antimicrobial Sales and Use (ASU) - Animal population data template
Other supporting materials for national competent authorities are available in the EU Network Training Centre (EU NTC), including webinar recordings.